Growing Trend of Subspecialization in Oncology Care
A recent study highlights the increasing trend of oncologist subspecialization, revealing regional and socioeconomic disparities in cancer care management across the US.
Subspecialization in oncology is becoming increasingly prevalent, though its application varies significantly across different cancer types and geographic regions. A recent study published online on August 12, 2025, in the Annals of Internal Medicine highlights this expanding trend. The research, led by Dr. Rene Karadakic from Harvard T.H. Chan School of Public Health, analyzed Medicare claims data spanning from 2007 to 2021 to assess how oncologists are narrowing their focus within cancer care.
The study defined subspecialization as managing more than 80% of chemotherapy treatments within a specific cancer category. Findings revealed that from 2008 to 2020, the proportion of chemotherapy episodes managed by subspecialists doubled, rising from 9% to 18% among over 18,600 oncologists and approximately 9.25 million chemotherapy episodes. Despite this overall increase, the utilization of subspecialized care showed notable variation depending on the cancer type and region, with the largest metropolitan areas exhibiting the highest levels of subspecialization.
Moreover, disparities related to income levels have widened over time. In 2020, 27.6% of episodes in high-income counties were managed by subspecialists, compared to just 8.8% in low-income counties, even though these lower-income areas experience higher cancer mortality rates. This raises important questions about the impact of subspecialist care on patient outcomes and whether patients under the care of subspecialists receive more guideline-adherent treatments or experience better health outcomes.
The researchers suggest that if further studies confirm improved outcomes linked to subspecialized oncology care, strategies and policies may be necessary to promote equitable access to subspecialty services, especially in underserved regions. Overall, this study underscores the evolving landscape of cancer treatment and the importance of understanding how subspecialization affects care quality across diverse populations.
For more detailed insights and data, refer to the original study: Link to article.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Severe Flu During Pregnancy Can Break Fetal Barriers in Mice, Allowing Harmful Molecules to Enter the Brain
Severe influenza infection during pregnancy can compromise fetal brain barriers, allowing harmful molecules to enter the developing brain and potentially impact neurodevelopment. Learn about the latest findings from Illinois researchers.
Innovative Low-Cost Drug Formulation Enhances Treatment for Parasitic Worms
A groundbreaking, affordable drug formulation improves efficacy against parasitic worms, reducing doses and facilitating global treatment efforts. Developed with nanotechnology, this innovation promises better accessibility for those affected by helminth infections worldwide.
Key Protein That Regulates Breast Cell Growth Could Help Prevent Cancer Spread
Researchers have identified a vital protein that controls breast cell growth and could be targeted to prevent cancer metastasis, opening new avenues for treatment.
Artificial Intelligence Predicts Future Diseases Up to 20 Years in Advance
A groundbreaking AI model, Delphi-2M, predicts the risk and timing of multiple diseases up to two decades ahead, marking a significant step toward proactive healthcare and personalized medicine.